FCF Biotech
Public Equity Monitor
The Biotech Public Equity Monitor is the most detailed and comprehensive valuation analysis for biotechnology and pharmaceutical companies in the micro, small and midcap market segment in Europe. Categorized by subsectors / indications, it provides relevant valuation metrics (e.g. ratios, multiples), general information, performance data, analyst consensus and shareholder analysis as well as statistics by region and subsector / indication.
FCF Biotech Public Equity Monitor
Share Price Potential...
Performance and Valuation..
Break-Even Analysis...
Liquidity Analysis...
Shareholder Analysis...
Previous slide
Next slide

As of the end of November 2021, we identify the following trends in Europe:

  • The overall price development of the European therapeutics sector rose by an average of +20% last year
  • Within the Therapeutics Sector, the Infectious Diseases sector recorded the highest share price performance within the last year with +125%, followed by Ophthalmology (+109%) and Respiratory (+52%)
  • Analysts see an average upside potential of +130% in the share prices of the European Therapeutics Sector
FCF Biotech Public Equity Monitor
Share Price Potential...
Performance and Valuation..
Break-Even Analysis...
Liquidity Analysis...
Shareholder Analysis...
Previous slide
Next slide
To receive a copy please click here

Capital Markets Research

We constantly engage in capital markets research to identify financing trends early in the Life Sciences sector. Our research focuses on the most relevant equity markets: Venture Capital, Public Equity, Initial Public Offerings (IPO). The findings are currently published in the following publications:

Venture Capital

Licensing

Monthly Venture capital activities in the European Life Sciences sector
Click Here
Healthcare & Life Sciences Venture Capital Monitor – Europe
Monthly Venture capital activities in the US Life Sciences sector
Click here
Biotech Venture Capital Monitor – USA
Recent Venture capital trends in the European Life Sciences sector
Click Here
Life Sciences Venture Capital Report
Recent licensing trends of European Biotech companies in China
Upcoming
Biotech Licensing Monitor – China
Monthly Venture capital activities in the European Life Sciences sector
Click Here
Healthcare & Life Sciences Venture Capital Monitor – Europe
Recent valuations of listed US Life Sciences companies
Click here
Biotech Venture Capital Monitor – USA/
Recent Venture capital trends in the European Life Sciences sector
Click Here
Life Sciences Venture Capital Report

Healthcare & Life Sciences Venture Capital Monitor – Europe
Monthly Venture capital activities in the European Life Sciences sector

Biotech Venture Capital Monitor – USA
Monthly Venture capital activities in the US Life Sciences sector

Life Sciences Venture Capital Report
Recent Venture capital trends in the European Life Sciences sector

Other Research

Recent IPO trends in the Life Sciences sector
Click Here
Life Sciences IPO Report
Recent valuations of listed European Life Sciences companies
Click Here
Biotech Public Equity Monitor
Recent valuations of listed MedTech companies
Click here
MedTech & Diagnostics Public Equity Monitor
Performance overview of merged Life Sciences SPACs
Click here
Life Sciences SPAC Monitor
Recent IPO trends in the Life Sciences sector
Click Here
Life Sciences IPO Report
Recent valuations of listed European Life Sciences companies
Click Here
Biotech Public Equity Monitor/
Recent valuations of listed MedTech companies
Click here
MedTech & Diagnostics Public Equity Monitor
Performance overview of merged Life Sciences SPACs
Click here
Life Sciences SPAC Monitor

Life Sciences IPO Report
Recent IPO trends in the Life Sciences sector

Biotech Public Equity Monitor
Recent valuations of listed European Life Sciences companies

MedTech & Diagnostics Public Equity Monitor
Recent valuations of listed MedTech companies

Life Sciences SPAC Monitor
Performance overview of merged Life Sciences SPACs

NEWS

more...